St Andrew’s Healthcare is on a continuous journey of improvement and transformation. We know that a research-positive culture will give our patients wider access to clinical research, leading to improved patient care and treatment options with evidence that clinically research-active hospitals have better patient care outcomes.
This opportunity has arisen from an exciting collaboration between St Andrew’s Healthcare and MeOmics Precision Medicine Ltd, a biotech start-up out of Cardiff University which resulted in a successful bid for Innovate UK funding for an innovative Neuronal Screening Platform for Improved Mental Health project (or NSP-4-IMH for short).
There has been relatively little recent progress in developing new therapies for psychotic disorders. This means that many people continue to suffer from symptoms even with the best current treatments. To improve these, it would be helpful to have a test that showed whether new therapies are likely to be effective or to better target existing medications to individual patients (personalisation). We want to conduct this study to see if measurements taken from cells derived from a blood test can help guide the development of new treatments for psychotic disorders and, in the longer term, help us select the right treatments for individuals more quickly through a precision psychiatry platform.
This role is suited to someone who has solid experience as a nurse, ideally (but not essentially) in a mental healthcare setting, and who would now like to develop their research skills. The opportunity for mentoring and training is covered within the role; this will include phlebotomy training and Good Clinical Practice (GCP) education (as required, based on the successful candidate’s existing skills).
The post-holder will play a key role in patient recruitment to the research study, and as such will need to be a team player and to be self-directed. They will ensure that Research Governance Guidelines and Good Clinical Practice are adhered to and maintain clinical trial study documentation. They will possess excellent organisational and communication skills and enjoy working with multi-disciplinary teams and have the ability to prioritise competing workloads. They will liaise with the St Andrew’s clinical and research teams as well as MeOmics Precision Medicine Ltd and Cardiff University.
The post is part time and on a fixed-term basis (equating to 22.5 hrs/3 days per week from 01 Oct 22 – 31 May 24). The role will be predominantly based at the Northampton site of St Andrew’s Healthcare, although it may involve some travel to our Birmingham site and to Cardiff.
Closing date: Shortlisting will start from Monday 15 August 2022, so application by Sunday 14 August is recommended as the post will close following recruitment.